Navigation Links
Michael A. Marletta Takes Office as New President of Scripps Research Institute

LA JOLLA, Calif., Jan. 2, 2012 /PRNewswire/ -- Renowned biochemist Michael A. Marletta, PhD, assumed the post of president and CEO of The Scripps Research Institute January 1, succeeding Richard A. Lerner, MD, who led the institution for more than two decades.

(Photo: )

"I'm excited by the opportunity to advance the institute's mission, creating knowledge in the biosciences and applying that knowledge to understanding and curing human disease," said Marletta. "I also look forward to working with all the dynamic, committed people who make the institute's work possible."

Marletta moved to Scripps Research from the University of California, Berkeley, where he served as chair of the Department of Chemistry, co-director of the Chemical Biology Graduate Program, Aldo DeBenedictis Distinguished Professor of Chemistry, and Professor of Biochemistry in the Department of Molecular and Cell Biology. He joined the Scripps Research faculty July 1, 2011, following his selection by the Board of Trustees as the institute's next head.

A former recipient of the prestigious MacArthur Fellowship as well as many other awards and honors, Marletta has focused his laboratory research on the intersection of chemistry and biology. He is an acknowledged pioneer in discovering the role of nitric oxide, a critical player in communication between cells.

Marletta is the third head of the institute in the 50 years since it began its focus on basic biomedical research. Its first director was Frank Dixon, MD, who arrived with his colleagues at the Scripps Clinic and Research Foundation (a forerunner of The Scripps Research Institute) in 1961 and was appointed head of research operations in 1970. Lerner, who had led the institute since 1987, will remain a member of the Scripps Research faculty.

For more information on Marletta, see his Scripps Research faculty web page at

About The Scripps Research Institute

The Scripps Research Institute is one of the world's largest independent, non-profit biomedical research organizations. Scripps Research is internationally recognized for its discoveries in immunology, molecular and cellular biology, chemistry, neuroscience, and vaccine development, as well as for its insights into autoimmune, cardiovascular, and infectious disease. Headquartered in La Jolla, California, the institute also includes a campus in Jupiter, Florida, where scientists focus on drug discovery and technology development in addition to basic biomedical science. Scripps Research currently employs about 3,000 scientists, staff, postdoctoral fellows, and graduate students on its two campuses. The institute's graduate program, which awards PhD degrees in biology and chemistry, is ranked among the top ten such programs in the nation. For more information, see

SOURCE Scripps Research Institute
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Michael Cusumano, MITs Sloan Distinguished Professor of Management, Joins Quantum Leap Innovations Board of Directors
2. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
3. NeuroCog Trials Appoints Industry Executive Michael Hufford, Ph.D. to Chief Operating Officer
4. Oramed Pharmaceuticals Appoints Dr. Michael Berelowitz as Chairman of Scientific Advisory Board
5. Netsmart Technologies Names Michael Valentine as Chief Executive Officer
6. BioNeutral Appoints Michael D. Francis, J.D. as Director to the Board
7. Michael J. Fox Foundation Awards Grant to Zymes LLC
8. Dr. Michael Hanley Joins Celtaxsys as CEO
9. NeuroDerm Awarded $1M by The Michael J. Fox Foundation for the Clinical Development of a New Dermal Patch for Parkinsons Disease
10. Vaccinogen Names Veteran Biotech Executive Michael Kranda President & CEO
11. Michael J. Fox Foundation Launches Parkinsons Progression Markers Initiative (PPMI)
Post Your Comments:
(Date:11/24/2015)... ... November 24, 2015 , ... Copper is an essential ... bound to proteins, copper is also toxic to cells. With a $1.3 million ... (WPI) will conduct a systematic study of copper in the bacteria Pseudomonas aeruginosa ...
(Date:11/24/2015)... , Nov. 24, 2015  Clintrax Global, Inc., a worldwide provider ... , today announced that the company has set a new ... 391% quarter on quarter growth posted for Q3 of 2014 to ... and Mexico , with the establishment of an ... 2015. --> United Kingdom and ...
(Date:11/24/2015)... ... November 24, 2015 , ... The Academy of Model Aeronautics (AMA), ... MultiGP, also known as Multirotor Grand Prix, to represent the First–Person View (FPV) racing ... AMA members have embraced this type of racing and several new model aviation pilots ...
(Date:11/24/2015)... Technologies Ltd. (OTCQB: TIKRF) today announced that its Annual General Meeting of ... Israel time, at the law offices of Goldfarb ... Floor, Tel Aviv, Israel . ... Tamir to the Board of Directors; , election of ... of an amendment to certain terms of options granted to our Chief ...
Breaking Biology Technology:
(Date:11/9/2015)... , Nov. 9, 2015  Synaptics Inc. (NASDAQ: ... today announced broader entry into the automotive market with ... match the pace of consumer electronics human interface innovation. ... are ideal for the automotive industry and will be ... Europe , Japan ...
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has been ... provide preclinical development services to the National Cancer Institute ... will provide scientific expertise, modern testing and support facilities, ... preclinical pharmacology and toxicology studies to evaluate potential cancer ... The PREVENT Cancer Drug Development Program is an ...
(Date:10/29/2015)... Calif. , Oct. 29, 2015  The J. ... new report titled, "DNA Synthesis and Biosecurity: Lessons Learned ... the Department of Health and Human Services guidance for ... in 2010. --> ... it also has the potential to pose unique biosecurity ...
Breaking Biology News(10 mins):